INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

74,087 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
FH
Fiore Michael HenryFormer EVP, CCO
HQYHEALTHEQUITY, INC.
Tax withholding
F$185K
2,032 sh
Oct 6, 2026Oct 8, 2026
Page 305 of 1853
← PrevNext →
traded Oct 6, 2026
+2d
SEC Form 4

Evidence

8
WK
Workman KurtPresident & CEO
OWLTOwlet, Inc.
Tax withholding
F$100K
20.4K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

8
HJ
Huang Jack JiajiaDirector, Chief Executive Officer, 10% Owner
COE51Talk Online Education Group
Tax withholding
F$42K
4,020 sh
Oct 2, 2026Oct 8, 2026
traded Oct 2, 2026
+6dSEC Form 4

Evidence

8
HJ
Huang Jack JiajiaDirector, Chief Executive Officer, 10% Owner
COE51Talk Online Education Group
Option exercise
M—
18.2K sh
Oct 1, 2026Oct 8, 2026
traded Oct 1, 2026
+7dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
120 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

7
HA
Haro AlexDirector
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M—
50.0K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
YR
Younessi RaminDirector
CRSCARPENTER TECHNOLOGY CORP
Grant or award
A—
361 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
GA
Girdwood AmyChief People & Culture Officer
WBDWarner Bros. Discovery, Inc.
Grant or award
A—
195.5K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
GW
Guggina David WExecutive Vice President
WMTWalmart Inc.
Tax withholding
F$12K
118 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Disposition to issuer
D—
156.8K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
AP
Aiyar PriyaChief Legal Officer
WBDWarner Bros. Discovery, Inc.
Grant or award
A—
948.7K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
HJ
Hart Anastasios JohnDirector
CRSCARPENTER TECHNOLOGY CORP
Grant or award
A—
361 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
YR
Younessi RaminDirector
CRSCARPENTER TECHNOLOGY CORP
Grant or award
A—
193 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
WL
Watkins LatrieceExecutive Vice President
WMTWalmart Inc.
Tax withholding
F$24K
227 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
HS
Hata Yujiro SDirector, President and CEO
IDYAIDEAYA Biosciences, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
800 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
HJ
Hart Anastasios JohnDirector
CRSCARPENTER TECHNOLOGY CORP
Grant or award
A—
193 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

5
GY
Gryzlov YuryCHIEF OPERATING OFFICER
GDYNGRID DYNAMICS HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$39K
4,849 sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

5
LC
Locke Lori C.Chief Accounting Officer
WBDWarner Bros. Discovery, Inc.
Grant or award
A—
61.1K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$31K
1,100 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$15K
499 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$27K
901 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

2
HS
Hata Yujiro SDirector, President and CEO
IDYAIDEAYA Biosciences, Inc.
Option exercise · 10b5-1 plan
M$114K
26.3K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

1
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
5,500 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,200
1,000 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,170
1,000 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

1
EE
Eberwein Jeffrey E.Director, Chief Executive Officer, 10% Owner
STRRStar Equity Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$9,170
1,000 sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

1
HJ
Hug JoshuaDirector
RELYRemitly Global, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
5,500 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
HS
Hata Yujiro SDirector, President and CEO
IDYAIDEAYA Biosciences, Inc.
Option exercise · 10b5-1 plan
M—
26.3K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
RS
Regnery David SDirector, Chair and CEO
TTTrane Technologies plc
Option exercise · 10b5-1 plan
M—
48.1K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Gift · 10b5-1 plan
G—
16.7K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

0
HA
Haro AlexDirector
LIFLife360, Inc.
Option exercise · 10b5-1 plan
M$126K
50.0K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
11.9K sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$144K
11.9K sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC Form 4

Evidence

63
BP
Barcos Melgar PabloVP INVESTMENT OFFICER
VTMXVesta Real Estate Corporation, S.A.B. de C.V.
Open-market sale
SELL$22K
6,154 sh
Aug 25, 2026Oct 7, 2026
traded Aug 25, 2026
+43dSEC Form 4

Evidence

52
Maria Elvira SalazarRSelf
SNOWSnowflake Inc.
Partial sale
SELL$1,001 – $15KSep 24, 2026Oct 7, 2026
traded Sep 24, 2026
+13dHouse PTR

Evidence

49
KJ
Knotnerus Tim JasperDirector, Chief Executive Officer
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$51K
6,000 sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC Form 4

Evidence